Rep. Dwight Evans discloses stock sales lagging S&P 500 on 30-day basis
The clip from BlindTrust presents Rep. Dwight Evans, D-PA, as having sold nine stocks with all underperforming the market on a forward basis. It highlights a May 7 sale of Thermo Fisher Scientific and notes his assignment to the Health subcommittee. The tone is mocking, with a repetitive chant-like close. BlindTrust derives its scores from periodic transaction reports filed under the STOCK Act. It compares each trade's 30-day performance to the S&P 500 and flags committee overlaps. The segment draws on eight prior scored trades with a mean alpha of -5.7%.
Source: BlindTrust